{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:00:27Z","timestamp":1783476027154,"version":"3.55.0"},"reference-count":32,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["N\/ST\/ZB\/16\/003\/1153"],"award-info":[{"award-number":["N\/ST\/ZB\/16\/003\/1153"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Galectin-3 (Gal-3) is a new independent risk factor in the development and severity of coronary artery disease (CAD). The aim of the study was to evaluate whether Gal-3 concentration has prognostic value and if it reflects the progression of atherosclerosis in carotid arteries in patients with CAD after acute myocardial infarction (AMI). The analysis included 110 patients who were hospitalized due to AMI, treated with primary coronary intervention (PCI) and further attended a follow-up visit, and 100 healthy volunteers. The Gal-3 concentration and carotid ultrasound were evaluated at baseline and on a follow-up visit. We found that the Gal-3 concentration in the group with hyperlipidemia decreased during the observation (10.7 vs. 7.9 ng\/mL, p = 0.00003). Patients rehospitalized during follow up had higher concentration of Gal-3 in the acute phase of myocardial infarction (MI) (10.7 vs. 7.2 ng\/mL, p = 0.02; 10.1 vs. 8.0 ng\/mL, p = 0.002, respectively). In the group of patients who had none of the following endpoints: subsequent MI, PCI, coronary artery bypass grafting (CABG) or stroke, there was a decrease in Gal-3 concentration at the follow-up visit. Parameters affecting the frequency of a composite endpoint occurrence are: the presence of atheromatous plaque in the carotid artery (p = 0.017), Gal-3 (p = 0.004) and haemoglobin (p = 0.03) concentration. In multivariate analysis, only Gal-3 concentration higher than 9.2 ng\/mL at discharge was associated with a nine-fold increase of risk of composite endpoint occurrence (p = 0.0005, OR = 9.47, 95% CI 2.60\u201334.45). A significant decrease in Gal-3 concentration was observed in the group of patients after AMI without the endpoint occurrence during observation.<\/jats:p>","DOI":"10.3390\/jcm9061640","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T09:19:27Z","timestamp":1591089567000},"page":"1640","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Galectin-3 as the Prognostic Factor of Adverse Cardiovascular Events in Long-Term Follow up in Patients after Myocardial Infarction\u2014A Pilot Study"],"prefix":"10.3390","volume":"9","author":[{"given":"Przemys\u0142aw","family":"\u015awi\u0119cki","sequence":"first","affiliation":[{"name":"Department of Cardiology, Medical University of Bia\u0142ystok, 15-276 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sawicki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Bia\u0142ystok, 15-276 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Knapp","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Bia\u0142ystok, 15-276 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-2581","authenticated-orcid":false,"given":"Karol Adam","family":"Kami\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Bia\u0142ystok, 15-276 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6457-704X","authenticated-orcid":false,"given":"Katarzyna","family":"Ptaszy\u0144ska-Kopczy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Bia\u0142ystok, 15-276 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Sobkowicz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Bia\u0142ystok, 15-276 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lisowska","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Bia\u0142ystok, 15-276 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2020.03.035","article-title":"Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures","volume":"507","author":"Pedersen","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/rth2.12087","article-title":"Galectin-3 in venous thrombosis: A possible new target for improved patient care","volume":"2","author":"Flaherty","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood-2014-04-569939","article-title":"The role of galectin-3 and galectin-3-binding protein in venous thrombosis","volume":"125","author":"DeRoo","year":"2015","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/CIRCHEARTFAILURE.111.963637","article-title":"Galectin-3 in ambulatory patients with heart failure: Results from the HF-ACTION study","volume":"5","author":"Felker","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","article-title":"Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction","volume":"43","author":"Lok","year":"2011","journal-title":"Ann. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0014-5793(98)00683-8","article-title":"Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells","volume":"430","author":"Arar","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/ATVBAHA.109.186791","article-title":"Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: Role of lipoxidation via receptor-mediated mechanisms","volume":"29","author":"Iacobini","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cvr\/cvt206","article-title":"The galectin-3\/RAGE dyad modulates vascular osteogenesis in atherosclerosis","volume":"100","author":"Menini","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/glycob\/cwt006","article-title":"Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"23","author":"MacKinnon","year":"2013","journal-title":"Glycobiology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.5551\/jat.12856","article-title":"Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention","volume":"19","author":"Tsai","year":"2012","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2016.01.022","article-title":"Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study","volume":"246","author":"Lisowska","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Goenka, L., George, M., Singh, V., Jena, A., Seshadri, D., Karunakaran, V., Elumalai, D.V., Rani, J., and Kaliappan, I. (2017). Do ANGPTL-4 and galectin-3 reflect the severity of coronary artery disease?. Ther. Adv. Cardiovasc. Dis., 1753944717723311.","DOI":"10.1177\/1753944717723311"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ahj.2012.08.021","article-title":"The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)","volume":"164","author":"Gullestad","year":"2012","journal-title":"Am. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000081812","article-title":"Mannheim intima-media thickness consensus","volume":"18","author":"Touboul","year":"2004","journal-title":"Cerebrovasc. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0301-5629(00)00353-7","article-title":"Acoustic shadowing on B-mode ultrasound of the carotid artery predicts CHD","volume":"27","author":"Hunt","year":"2001","journal-title":"Ultrasound Med. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijcard.2014.08.011","article-title":"Galectin-3 is essential for early wound healing and ventricular remodeling after myocardial infarction in mice","volume":"176","author":"Cassaglia","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MCA.0000000000000252","article-title":"Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden\/structure in patients with type 2 diabetes mellitus","volume":"26","author":"Ozturk","year":"2015","journal-title":"Coron. Artery Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejvs.2014.10.009","article-title":"Galectin-3, Carotid Plaque Vulnerability, and Potential Effects of Statin Therapy","volume":"49","author":"Kadoglou","year":"2015","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"40994","DOI":"10.1038\/srep40994","article-title":"Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke","volume":"7","author":"He","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/STROKEAHA.117.019084","article-title":"Serum Galectin-3 and Poor Outcomes Among Patients With Acute Ischemic Stroke","volume":"49","author":"Wang","year":"2018","journal-title":"Stroke"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zeng, N., Wang, A., Zhong, C., Zheng, X., Zhu, Z., Xu, T., Peng, Y., Peng, H., Li, Q., and Ju, Z. (2018). Association of Serum Galectin-3 with Risks of Death and Vascular Events in Acute Ischemic Stroke Patients: The Role of Hyperglycemia. Eur. J. Neurol.","DOI":"10.1111\/ene.13856"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4070\/kcj.2013.43.4.223","article-title":"Spatial and temporal expression, and statin responsiveness of galectin-1 and galectin-3 in murine atherosclerosis","volume":"43","author":"Lee","year":"2013","journal-title":"Korean Circ. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/00365513.2014.928944","article-title":"Association of small, dense low-density lipoprotein cholesterol and galectin-3 in patients with chronic kidney disease","volume":"74","author":"Savic","year":"2014","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_25","first-page":"2048004017729984","article-title":"Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study","volume":"6","author":"Laake","year":"2017","journal-title":"JRSM Cardiovasc. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2217\/bmm-2017-0178","article-title":"Galectin-3 and outcomes after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention","volume":"12","author":"Caretta","year":"2018","journal-title":"Biomark. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e3093","DOI":"10.1002\/dmrr.3093","article-title":"Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes","volume":"35","author":"Tan","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.hlc.2016.11.007","article-title":"Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling","volume":"26","author":"Sharma","year":"2017","journal-title":"Heart Lung Circ."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1373\/clinchem.2016.257550","article-title":"Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study","volume":"62","author":"Jansen","year":"2016","journal-title":"Clin. Chem."},{"key":"ref_30","first-page":"4979","article-title":"Significance of Circulating Galectin-3 in Patients with Pancreatobiliary Cancer","volume":"37","author":"Shimura","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000497611","article-title":"Galectin-3 in Acute Myocardial Infarction Patients with Atrial Fibrillation","volume":"28","author":"Stanojevic","year":"2019","journal-title":"Med. Princ. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S583","DOI":"10.4103\/0973-1482.176425","article-title":"The clinical importance of serum galectin-3 levels in breast cancer patients with and without metastasis","volume":"14","author":"Topcu","year":"2018","journal-title":"J. Cancer Res. Ther."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/6\/1640\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:33:46Z","timestamp":1760175226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/6\/1640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["jcm9061640"],"URL":"https:\/\/doi.org\/10.3390\/jcm9061640","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]}}}